The influence of spin-labeled fluorene compounds on the assembly and toxicity of the aβ peptide. by Petrlova, Jitka et al.
UC Davis
UC Davis Previously Published Works
Title
The influence of spin-labeled fluorene compounds on the assembly and toxicity of the aβ 
peptide.
Permalink
https://escholarship.org/uc/item/6w79g1sh
Journal
PloS one, 7(4)
ISSN
1932-6203
Authors
Petrlova, Jitka
Kálai, Tamás
Maezawa, Izumi
et al.
Publication Date
2012
DOI
10.1371/journal.pone.0035443
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
The Influence of Spin-Labeled Fluorene Compounds on
the Assembly and Toxicity of the Ab Peptide
Jitka Petrlova1, Tama´s Ka´lai2, Izumi Maezawa3, Robin Altman1, Ghimire Harishchandra4, Hyun-
Seok Hong3, Daniel A. Bricarello5, Atul N. Parikh5, Gary A. Lorigan4, Lee-Way Jin3, Ka´lma´n Hideg2,
John C. Voss1*
1Department of Biochemistry and Molecular Medicine, University of California Davis, Davis, California, United States of America, 2 Institute of Organic and Medicinal
Chemistry, University of Pe´cs, Pe´cs, Hungary, 3 Laboratory Medicine, Department of Pathology, M.I.N.D. Institute, Miami University, Oxford, Ohio, United States of America,
4Department of Chemistry and Biochemistry, Miami University, Oxford, Ohio, United States of America, 5Department of Applied Science, University of California Davis,
Davis, California, United States of America
Abstract
Background: The deposition and oligomerization of amyloid b (Ab) peptide plays a key role in the pathogenesis of
Alzheimer’s disease (AD). Ab peptide arises from cleavage of the membrane-associated domain of the amyloid precursor
protein (APP) by b and c secretases. Several lines of evidence point to the soluble Ab oligomer (AbO) as the primary
neurotoxic species in the etiology of AD. Recently, we have demonstrated that a class of fluorene molecules specifically
disrupts the AbO species.
Methodology/Principal Findings: To achieve a better understanding of the mechanism of action of this disruptive ability,
we extend the application of electron paramagnetic resonance (EPR) spectroscopy of site-directed spin labels in the Ab
peptide to investigate the binding and influence of fluorene compounds on AbO structure and dynamics. In addition, we
have synthesized a spin-labeled fluorene (SLF) containing a pyrroline nitroxide group that provides both increased cell
protection against AbO toxicity and a route to directly observe the binding of the fluorene to the AbO assembly. We also
evaluate the ability of fluorenes to target multiple pathological processes involved in the neurodegenerative cascade, such
as their ability to block AbO toxicity, scavenge free radicals and diminish the formation of intracellular AbO species.
Conclusions: Fluorene modified with pyrroline nitroxide may be especially useful in counteracting Ab peptide toxicity,
because they posses both antioxidant properties and the ability to disrupt AbO species.
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Introduction
Alzheimer’s disease (AD) is characterized by the deposition of
various amyloid b (Ab) aggregates forming amyloid in the brain.
Evidence from a variety of studies has established that the
oligomeric species of Ab (AbO) carries the greatest toxicity,
triggering a variety of downstream effects resulting in neurotoxicity
and cognitive deficits [1,2,3,4]. A major impediment to the
development of effective anti-Ab compounds for AD therapy is
that essentially 100% of large-molecule drugs and .98% of small-
molecule drugs fail to cross the blood-brain barrier (BBB) [5].
Recently [6], we explored a series of compounds based on a highly
rigid tricyclic fluorene ring that were developed as amyloid
imaging agents [7]. These compounds contain a tertiary amine
electron-donating group attached to one aromatic ring and display
excellent pharmacokinetics properties and brain bioavailability. In
that work, we reported on the ability of two fluorene compounds
to disrupt AbO assemblies and reduce Ab toxicity [6]. These
compounds (K01-162 and K01-186) were identified based on their
ability to block cell death secondary to intracellular AbO
production. Both fluorene compounds bind and destabilize
AbO, and are capable of penetrating the brain and reducing the
cerebral amyloid burden in APP transgenic mice. Fluorenes
therefore have a potential use in AD therapy by targeting AbO
toxicity at both intraneuronal and extracellular sites [6,8].
In AD, accumulating evidence points to oxidative stress as the
ultimate downstream component of Ab-induced toxicity [9,10].
For example, Ab increases NMDA receptor activation, and one of
the newer drugs for the treatment of AD (Memantine) targets
NMDA receptors in order to block glutamate excitotoxicity.
Among other pathways, over-stimulation of NMDA receptors
activates phospholipase A, leading to elevated arachidonic acid
levels, which in turn generates oxygen free radicals and further
activation of phospholipases [11]. Thus the excitotoxicity involves
a feedback loop that ultimately leads to neuronal self-digestion via
increased Ca2+ levels, protein breakdown, free radical formation
and lipid peroxidation [10]. As shown previously [6], the anti-
amyloid fluorenes have antioxidant properties. Furthermore,
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because nitroxides such as the pyrroline species can cycle within a
redox cascade via a relatively stable non-damaging N-oxyl
(nitroxyl) radical intermediate [12,13], compounds carrying this
moiety are likely to have the added potential for decreasing
oxidative stress and attenuating the damage caused by reactive
oxygen species.
In this study, we apply electron paramagnetic resonance (EPR)
spectroscopy to a novel fluorene compound containing a pyrroline
nitroxide. This spin-labeled fluorene (SLF) exerts similar potency
in AbO disruption and protection against AbO-induced toxicity,
while also having superior free radical scavenging compared to the
model fluorene compounds. Furthermore, the nitroxide moiety
provides an intrinsic reporter group that can be probed by EPR
spectroscopy, which may provide a sensitive diagnostic tool for in
vivo detection of Ab plaques in patients with AD [14]. Thus, in
addition to its potential as a novel bifunctional candidate to
address AbO toxicity, the SLF compound may also help as a
diagnostic and research tool in elucidating fluorene mechanism of
action.
Results and Discussion
Bifunctional structure of spin-labeled fluorenes
Previously [6], we found the substituted fluorene 7-bromo-2-
N,N-dimethylaminofluorene (K01-162) is able to reduce the
amyloid burden in mice and block Ab toxicity in cultured
neurons. In addition, K01-162 binds and disaggregates Ab in its
toxic, soluble oligomeric state (AbO). In order to extend the
experimental, diagnostic and therapeutic potential of the fluorene
agents, the methyl group of dimethylamino was replaced with a
pyrroline or piperdine ring to incorporate a spin probe on the
fluorene ligand [15]. The structure of spin-labeled fluorene (SLF)
HO-4160 (7-bromo-N-methyl-N –[(2,2,5,5-tetramethyl-2,5-dihy-
dro-1H-pyrrol-3-yl)methyl]-9H-fluoren-2-amine radical) is shown
in Figure 1.
SLFs protect against AbO toxicity in cultured neurons
As demonstrated earlier [6,8] K01-162 attenuates intracellular
AbO accumulation and protects against AbO-induced toxicity in
cultured neurons. To test the efficacy of SLFs to block Ab toxicity
in cultured neurons, we examined the potential of a recently
described class of SLF molecules to influence the survivability of
MC65 neuroblastoma cells [16] containing conditional expression
of the C-terminal region (C99) of the amyloid precursor protein
(APP). In the MC65 model system, expression of the APP
fragment is turned on in the absence of the transgene suppressor,
tetracycline (TC). Upon APP-C99 induction, Ab is generated after
proteolysis by cellular c-secretase [16]. As shown in Figure 2, the
viability of cells is severely diminished when the expression of APP-
C99 is turned on (2TC), compared to the control cells (+TC)
lacking Ab generation. However, increasing levels of SLF HO-
4160 restore cell viability to near control levels, with an EC50 of
30 nM. This response is superior to the K01-162 model fluorene
(Figure 2, inset). At concentrations above 1 mM, the viability of
both APP-induced and un-induced cells declines, reflecting a
tolerance limit of the cells to the SLF.
As mentioned above, HO-4160 is one of a group of related SLF
compounds that we have recently described [15]. We also
measured the ability of the other related SLF analogs (see Fig.
S1 in Supporting Information) to block Ab toxicity. As shown in
Table 1, except for compound 5 in this series, each of the
compounds offers protection with potency comparable or superior
to K01-162. Because HO-4160 provides the greatest amount of
protection against Ab toxicity, we therefore selected this SLF for
more detailed analysis of its molecular effects on AbO.
SLF HO-4160 reduces AbO accumulation in cultured
neurons
Our results clearly demonstrate the protective effect of SLF
HO-4160 on MC65 cells expressing APP-C99. To determine
whether this protective effect corresponds to a reduction in the
AbO burden of the cells, we used both Western blot and
immunofluorescent staining to analyze the AbO levels in SLF-
treated cells. Western blot analysis of MC65 cellular extracts
reveals decreased levels of AbO assemblies of varying sizes in SLF-
treated cells expressing APP-C99 (2TC) compared to control cells
(+TC). As shown in Figure 3, the Ab fragments produced by c-
secretase action fail to form any readily apparent oligomers when
the cells are treated with 300 nM HO-4160. Complementary
results were achieved by using immunofluorescence to probe for
AbO using the oligomer-specific antibody A11 [17]. Figure 4
shows greatly decreased levels of AbO assemblies in MC65 cells
expressing APP-C99 and treated with SLF (Fig. 4D), compared to
untreated cells (Fig. 4B). These results indicate that not only does
SLF HO-4160 block the toxic effects associated with Ab
production in cultured neuronal cells, but also directly attenuates
the formation of oligomeric Ab species in the same model.
Figure 1. Diagram showing the locations of spin labels in Ab(1–40),
and the structures of the HO-4160 and K01-162 fluorene
compounds. Top panel:. the spin labels were targeted to either
position 2 (MTS nitroxide spin label) or position 26 (TOAC nitroxide spin
label) of Ab. Position 26 lies within a putative hairpin loop connecting
the terminal domains of the peptide, while position 2 is found within
the N-terminal domain. Bottom panel: the structure of the SLF
compound HO-4160, which is a derivative of the active fluorene K01-
162 described in [6]. The core fluorene ring structure is shown in red.
doi:10.1371/journal.pone.0035443.g001
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Disruption of AbO aggregates by SLF
To test whether SLF HO-4160 blocks the formation of AbO
assemblies that can be imaged by atomic force microscopy (AFM)
[6], we acquired AFM images of Ab preparations (50 mM peptide)
incubated in PBS buffer for 1 hour, with and without 50 mM SLF
treatment. As shown in Figure 5 (A&B), there is a lack of particles
.5 nm when Ab is incubated with the SLF. We also tested
whether SLF decreases the formation of particles rich in beta-
strand secondary structure using the amyloidophilic dye thioflavin
T (ThT). When SLF is included in a 24-hour incubation of Ab, the
ThT fluorescence is decreased by nearly one-half (Fig. 5C). Both
the AFM and ThT observations are consistent with a mechanism
where the protective activity of HO-4160, like fluorene K01-162,
is related to its ability to bind and disaggregate Ab.
EPR spectroscopy detects the binding of SLF to Ab
Due to its small size, the rotational diffusion of the SLF
molecule when free in solution will average the hyperfine
anisotropy of its EPR spectrum, producing the narrow, time-
averaged line shape seen in Figure 6 (black line) indicative of sub-
nanosecond diffusion. However, in the presence of AbO,
substantial broadening of the SLF (10 mM) signal is apparent
(Fig. 6, red line). The most likely cause of the spectral broadening
is a reduction in the rate of rotational diffusion by the SLF
molecule in solution upon binding to the Ab peptide. While a
small broad peak appears to arise uniquely in the sample
containing AbO (see arrow, Fig. 6), we are unable to resolve this
feature sufficiently above background. Therefore it is difficult to
conclude with certainty whether the resulting spectrum of the SLF
in the presence of Ab represents the compound docked to a
mixture of monomers and higher oligomers, or a mixture of bound
and unbound SLF. Given the high affinity of fluorenes for AbO
[6], we expect that the SLF compound is entirely occupied by the
excess Ab peptide.
Oligomerization of Ab as reported by peptide containing
the TOAC spin label at position 26
We recently [18] reported on Ab synthesized with a TOAC spin
label positioned in the central region of the peptide, at position 26
(Ab(26TOAC)). TOAC is a backbone-restricted nitroxide that offers
improved detection of the dynamics arising from movement of a
peptide’s backbone and/or global rotational diffusion. We have
previously shown that the local backbone at position 26 is
sufficiently ordered such that the EPR spectrum of Ab(26TOAC) is
sensitive to changes in the peptide’s rate of global rotational
diffusion [18]. Since oligomerization of Ab(26TOAC) will have
profound effects on the rate of global rotational diffusion, this
modified peptide provides direct insights into the oligomeric state
of Ab in solution. As shown in Figure 7A, there is a time-
dependent broadening of the Ab(26TOAC) EPR line shape,
consistent with an increasing molecular volume resulting from
oligomerization. Because of the close proximity of peptides in
AbO, the samples in Figure 7A contained a 25% molar fraction of
Ab(26TOAC) that was spin-diluted with wild-type Ab. Thus the
increased line-broadening in these samples can be attributed to
changes in spin-label correlation time, and not spin coupling.
However, the strong influence of dipolar coupling in the oligomer
Figure 2. SLF HO-4160 protects against AbO toxicity in cultured neurons. Plotted are the viability values for neuroblastoma MC65 cells with
conditional APP-C99 expression as a function of compound concentration. The protective effect against AbO toxicity exceeds that of the previously
described base compound, K01-162 (insert).
doi:10.1371/journal.pone.0035443.g002
Table 1. Potency of SLF compounds [15] against Ab toxicity
as determined by the MTT assay.
Compound EC50 (mM) Tx50 (mM)
3a (HO-4160) 0.03 3.1
3b 0.05 1.4
3b/OH/2HCl 0.1 2.5
3c 0.05 1.3
3d 0.1 2.3
4 0.07 1.6
5 1.2 3.1
K01-162 0.12 10
The structures of 3a and K01-162 are shown in Fig. 1, see Fig. S1 in Supporting
Information for other structures.
doi:10.1371/journal.pone.0035443.t001
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is evident if spin dilution of Ab(26TOAC) is not carried out
(Figure 7B).
Effects of SLF observed by spin labels located within Ab
As shown previously [6], the dynamics of Ab containing a spin
label near its N-terminus serve to indicate the disruption of AbO
by active fluorene compounds. Because AbO disruption should be
accompanied by increased rates of global rotational diffusion in
solution, the spin labels attached to Ab provide an additional
means of observing AbO disruption by the SLF. Furthermore, if
the proximity of the nitroxide moieties located on the fluorene
ligand and the Ab peptide are close enough to interact
magnetically, the dipolar broadening may be evident in the
composite spectrum.
As shown in Figure 8, 2 hours after addition of the compound to
AbO harboring a spin label at position 2 or 26, the spectrum
greatly increases in amplitude (red trace). This demonstrates that
the SLF is able to greatly disrupt the AbO after 2 hours. Since spin
labels are only attached to 25% of the Ab peptides, the level of
broadening suggests the nitroxides on the oligomeric peptides can
interact with more than one docked fluorene. This is supported by
the observation that after complete disruption of AbO, there is a
large increase in the spectral amplitude. Some increase in the
amplitude is expected due to faster diffusion of monomeric Ab
[18]. Our investigation of the ability of 10 mM SLF to disrupt
oligomers formed after 24 hours produced varied results that most
likely reflect the heterogeneity of assembly size and structure, some
of which appear to be resistant to SLF disruption.
Figure 3. SLF HO-4160 greatly diminishes the intracellular population of oligomeric Ab Shown are Western blots of extracts from
the MC65 human neuroblastoma cell line that conditionally expresses C99, a 99-residue carboxyl terminal fragment of APP in the
absence of tetracycline (2TC). C99 is subsequently cleaved by cellular c-secretase to generate Ab. TP17, an inactive tricyclic pyrone, serves as a
negative control [31], while vitamin E (Vit E), a potent antioxidant that was shown to also block AbO formation in MC65 cells [30], serves as a positive
control. p8 is an unresolved band that could be an Ab homodimer, or a heterodimer of Ab and APPD31 [31], a caspase cleavage product involving
residues just downstream from the Ab origin on APP. The presence of this band does not correlate with MC65 cell death [31]. Blotting was carried out
using the Ab antibody 6E10 (upper panel) and the loading control (lower panel) was probed using an antibody directed against b-actin. The blot
shown is representative of 3 replicates.
doi:10.1371/journal.pone.0035443.g003
Figure 4. SLF blocks the appearance of oligomeric Ab species
within cultured cells. MC65 cells were treated with the indicated
compounds (1 mM) immediately after the removal of the transgene
suppressor tetracycline (2TC; panels B–D) to induce AbO accumulation.
At 24 hours, cells were fixed, immunofluorescently stained with the
oligomer-specific antibody A11 (red) and counterstained with the
nuclear dye DAPI (blue). As shown in panel (D), the cytoprotective SLF
HO-4160, as well as the antioxidant vitamin E (Vit E) attenuate the
accumulation of intracellular AbO (red fluorescent puncta).
doi:10.1371/journal.pone.0035443.g004
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Interaction between the nitroxides on the SLF ligand and
Ab
Figure 9 compares EPR spectra from the following conditions
using Ab spin-labeled at either position 2 or 26: a sample
containing spin-labeled AbO alone, a sample containing both
spin-labeled AbO and SLF, and a composite spectrum generated
from the individual SLF and spin-labeled AbO spectra. From
these comparisons, it is evident that both of the spin-labeled
positions in AbO show at least some interaction with the nitroxide
moiety on the SLF. This is based on the observation that the
spectrum of the sample with both species labeled is lower in
amplitude than the sample containing labeled AbO alone. Position
26 in Ab (Fig. 9B) experiences a stronger interaction with the SLF
than position 2 of Ab (Fig. 9A). The blue trace in Figure 9A or 8B
is a sum of the individual spectra of the two spin-labeled species
(Ab and SLF,) and indicates what the actual mixed sample
spectrum would look like if no interaction were present. However,
the observed spectrum of the mixed sample (black trace) is lower
than the composite spectrum. The broadening of the mixed
spectrum is slight when Ab contains the spin label at position 2,
indicating the nitroxide of SLF approaches within 2 nm of the N-
terminal region. However, the broadening of the sample
containing a spin label at position 26 is more substantial,
demonstrating the nitroxide of SLF is in closer proximity
(1.5 nm or less).
Circular dichroism analysis of SLF influences on Ab
Circular dichroism (CD) spectroscopy provides a global
indicator for the increase in beta-strand content that accompanies
the oligomerization of the Ab peptide [19]. To determine whether
SLF affects the transition of Ab monomers into secondary
structures, CD spectra of Ab were collected immediately after its
initial introduction into aqueous buffer and then throughout a
time course of 24 hours. In the absence of SLF, the CD spectra of
Ab reflect a transition from an unstructured random coil to a
spectrum characteristic of beta-strand secondary structure (Fig. 10)
[20]. The most substantial effect of SLF on the CD spectrum of Ab
is seen at 1 hour, where in the absence of SLF the spectrum shows
a distinct beta absorption pattern. However in the presence of
SLF, the peptide maintains a largely disordered structure after
Figure 5. Clearance of AbO aggregates observed by AFM imaging and ThT binding assay. Small oligomers used in this study are formed
within 60 minutes (scale bar 10 nm). The direct visualization of oligomers by using AFM revealed the formation of AbO aggregates. (A) 50 mM of Ab
after 24 hours of incubation at room temperature (diameter 5–10 nm). B) 50 mM of Ab and 50 mM of SLF after 24 hours of incubation at room
temperature. (C) Staining for beta-rich assemblies by the amyloid dye thioflavin T for incubations of Ab with and without SLF HO-4160 as described in
Methods. Data are the averages from 3 separate experiments with the error bars representing the SEM.
doi:10.1371/journal.pone.0035443.g005
Figure 6. EPR examination indicates the motional freedom of SLF is reduced by interaction with AbO. AbO imparts a broad component
(arrow) into the EPR spectrum of HO-4160, reflecting a population of SLF with a slower correlation time.
doi:10.1371/journal.pone.0035443.g006
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1 hour. Although SLF does slow the development of beta
secondary structure, by 24 hours the CD spectrum of Ab in the
presence of SLF shows strong absorption in the wavelength range
that interacts most efficiently with a beta-sheet fold. As shown in
Figure 10, however, the 24-hour spectra for Ab in the presence
and absence of SLF are significantly different, suggesting a unique
conformation for the peptide in the presence of SLF. This is not
unexpected, as the peptide’s structure likely adopts a distinct fold
as it incorporates into larger assemblies. As the neurotoxicity of Ab
correlates more strongly with aggregative ability than secondary
structure [21], compounds that influence the former provide better
candidates for intervening in the molecular pathology of AD.
SLF scavenges free radicals
Sterically hindered alpha, alpha9-tetrasubstituted 5-membered
cyclic secondary amines are sensitive to oxidation by ROS to N-
oxyls. In turn, the N-oxyls can be oxidized to the N-oxoimmo-
nium, or reduced to diamagnetic N-hydroxylamines [22,23,24]. A
major advantage of the N-oxyl radical is that it represents a stable
free radical that does not induce damage to DNA, proteins, lipids
or sugars. Thus, this added feature of the fluorene should improve
its ability to lower oxidative stress by either donating or accepting
electrons with radicals (NR), such as reactive oxygen species
(NROS).
To measure the free-radical scavenging potential of candidate
compounds, spin-trapping in the presence and absence of SLF was
measured by EPR spectroscopy to look for the depletion of
superoxide and hydroxyl radicals. The EPR spectra of BMPO
adducts with superoxide and hydroxyl radicals (generated via
horseradish peroxidase/H2O2 and ironsulfate/H2O2, respectively)
are shown in green (Fig. 11). The spectrum in the presence of SLF
is shown in red, reflecting a decrease in the amount of BMPO
adduct formed. The antioxidant activity of the SLF further
extends to cellular systems. In the same MC65 neuroblastoma cell
model described previously, addition of SLF attenuates the
production of hydrogen peroxide in response to APP-C99
expression (2TC) compared to control cells (+TC) lacking APP-
C99 (Fig. 12). The reduced hydrogen peroxide production
approaches control levels and is similar to the reduced levels
achieved by treatment of Ab-generating cells with the antioxidant
vitamin E.
Summary
We have previously shown that selected fluorene compounds
can rapidly disrupt AbO in solution, and dramatically attenuate
AbO toxicity in vivo [6]. The results reported here demonstrate
how SLFs help elucidate the mechanism of fluorene action and,
more importantly, that SLFs have superior potency in alleviating
AbO-induced toxicity. Simulations of the SLF parent K01-162
and Ab(1–42) show preferential interaction of the compound with a
hydrophobic core region of the peptide constituted by residues 17–
21 [25]. Figure 13 illustrates one potential mode of interaction
between AbO and SLF consistent with our findings regarding
substituted fluorenes [6], where the binding of SLF to Ab occludes
a hydrophobic interface that facilitates peptide oligomerization.
Materials and Methods
Materials
Spin-labeled fluorene HO-4160 (7-Bromo-N —[(1-Oxyl-
2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)methyl]-9H-fluoren-
2-amine radical) was synthesized as previously described [15].
Peptide labeled at position 26 (Ab(26TOAC)) was synthesized with the
TOAC nitroxide incorporated at position 26 as previously described
[18]. Peptide labeled at position 2 (Ab(2R1)), was first synthesized with
a Cys residue substituted at position 2, and then reacted with the
methanethiosulfonate spin label (MTS-SL) [26], as previously
described [6]. The structures and approximate locations of each
spin label are indicated in Figure 1. MC65 cells were generated by
Sopher et. al. [27], and gifted to L-W.J.
Preparation of Ab oligomers
Solid Ab(1–40) peptide (Bachem Cat # 1194.0001, Torrance,
CA) was dissolved in Hexa-Fluoro-Iso-Propanol (HFIP, Sigma, St.
Louis, MO). The solution was incubated at room temperature for
1 day until the solution became clear and colorless. HFIP is a
strong reducing reagent that can break hydrogen bonds and keep
Ab(1–40) in the monomeric form. All the HFIP was removed by
Figure 7. Spectral broadening due to immobilization and dipolar interaction in assemblies of Ab. (A) Changes in the correlation time of
Ab(26TOAC) with increased incubation time. To mainly observe the effects on dynamics, the spins in the Ab preparation were diluted with wild-type
peptide (Ab(1–40)), so that the sample contained only 25% Ab
(26TOAC). (B) Comparisons of EPR spectra of 80 mM AbO preparations containing either
25% (black line) or 100% (red line) Ab(26TOAC). Both spectra were acquired after 1 hour at room temperature.
doi:10.1371/journal.pone.0035443.g007
A Spin-Labeled Ligand against Ab Toxicity
PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e35443
SpeedVac Concentrator (Savant, SV100H, Thermo Scientific,
Waltham, MA). To generate Ab(1–40) oligomers, a 100% DMSO
stock solution of 1 mM Ab(1–40) was diluted in cold PBS buffer
pH 7.4 to a total concentration of 100 mM. For EPR experiments
using spin-labeled Ab, the AbO preparations contained a mixture
of 25% spin-labeled peptide to 75% native Ab(1–40). This dilution
of labeled peptide in the AbO sample minimizes the broadening of
the EPR spectrum that arises from the dipolar interaction of spins
in close proximity (,2 nm) [28].
Cell culture models exhibiting intraneuronal AbO
The cell culture model used for these studies was the human
neuroblastoma cell line (MC65) equipped with conditional
expression of the carboxyl-terminal 99 residues of the amyloid-b
precursor protein (APP-C99). Ab is generated from APP-C99 after
proteolysis by cellular c-secretase. To induce cellular Ab
production, the transgene suppressor, tetracycline (TC), was
removed from the media, as described previously [3]. Intracellular
AbO started to accumulate as early as 4 hours after TC removal.
The cytotoxicity was determined on day 3 using a colorimetric
MTT [3-(4,5-dimethylthiazol-2yl)-2,5-diphenyltetrazolium bro-
mide] assay, the results of which were comparable to data
obtained using counts of viable cells based on trypan blue
exclusion and the LIVE/DEAD assay (Invitrogen, Grand Island,
NY). To test the fluorene compounds, the compounds were added
Figure 8. Fluorenes bind AbO and destabilize highly organized secondary structure. EPR spectra of SLF (10 mM) with single-cysteine
mutant Ab(1–40) oligomers (40 mM) show that motional freedom of the mixture increased following a 2-hour incubation at room temperature (red)
compared with 0 hours (black). A) and B) 26 AbO: spin labeled at 26th residue C) and D) 2 AbO: spin labeled at 2nd residue.
doi:10.1371/journal.pone.0035443.g008
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immediately after TC removal, and the cells were maintained for 3
days without media change before the MTT assay.
Western blotting
The preparation of cell homogenates and Western blotting were
performed as previously described [29,30].
Immunofluorescence staining
Immunofluorescent labeling of AbO in cultured MC65 cells by
the A11 anti-oligomer antibody (Chemicon-Millipore, Billerica,
MA) was performed according to our previously published
protocols [16].
Atomic force microscopy (AFM)
AFM was employed to analyze the oligomer formation of wild-
type AbO. All surface scans employed a Dimension 3100
Scanning Probe Microscope with a Hybrid closed-loop XYZ
Figure 9. The comparison of EPR spectra from Ab alone, an
actual mixture of SLF and Ab, and the mathematical sum of the
individual EPR signals from SLF and Ab. Data were taken for
samples containing AbO spin labeled at the 2nd residue (A) and for
samples containing AbO spin labeled at the 26th residue (B).
doi:10.1371/journal.pone.0035443.g009
Figure 10. Circular dichroism analysis of secondary structural
changes in Ab. The time zero (t = 0) trace was obtained by scanning
Ab immediately after introduction into buffer. Inclusion of SLF had no
significant effect on the t = 0 spectrum (not shown). Additional traces
were obtained at 1, 2, 4, 6 and 24 hours. For both the control and +SLF
samples, the t = 2, 4, and 6 hour traces are not shown, as these curves
changed in a stepwise manner between the t = 1 and t = 24 hour time
points. See Methods for additional details.
doi:10.1371/journal.pone.0035443.g010
Figure 11. The EPR spectra of BMPO adducts with hydroxyl (A)
and superoxide (B) radicals (generated via ironsulfate/H2O2
and horseradish peroxidase/H2O2, respectively) are shown in
green. The spectra in the presence of SLF are shown in red, reflecting a
decrease in the amount of BMPO adduct formed. Based on the
difference in the spectral intensities of the generated BMPO-adduct, SLF
HO-4160 is able to scavenge approximately 80% and 25% of the
superoxide and hydroxyl radicals, respectively.
doi:10.1371/journal.pone.0035443.g011
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head and Nanoscope IVa controller (Vecco, Santa Barbara, CA).
All samples were prepared on freshly-cleaved mica (Ted Pella,
Redding, CA) and imaged in tapping mode in air by a
phosphorous-doped silicon cantilever with a nominal spring
constant of 40 N/m. Particle dimension measurements and image
enhancement were performed with the Nanoscope software
supplied by Veeco, version 6.14. For each measurement, an
aliquot of AbO was removed from the 1 mM DMSO stock
solution and diluted to 50 mM of AbO in PBS pH 7.4, and
immediately spotted on freshly cleaned mica. After 2 minutes the
samples were washed with 200 mL distilled water and then
partially dried by compressed air and completely dried at room
temperature [6].
Thioflavin T (ThT) binding assay
Ab(1–40) (40 mM) in the presence or absence of SLF (10 mM) was
incubated at room temperature for 24 hours. Ab(1–40) (20 mL) with
or without SLF was incubated in 170 mL PBS buffer and 10 mL
ThT (ThT stock: 0.1 mM stored in the dark at 4uC) for
15 minutes in the dark. Then ThT fluorescence was measured
by a VICTOR3 Multilabel Plate Counter (PerkinElmer, Wal-
tham, MA) spectrofluorometer at an excitation of 450 nm, with
excitation and emission slit widths of 10 nm.
Circular dichroism spectroscopy
CD measurements were performed on a Jasco J-810 spectro-
polarimeter equipped with a Jasco CDF-426S Peltier set to 25uC
(Jasco, Easton, MD). Ab(1–40) was diluted to 40–80 mM in
phosphate buffer (25 mM, pH 7.4). SLF in DMSO (final
concentration 10–20 mM) or DMSO alone (final concentration
0.01–0.02%) was added to the Ab, and the samples incubated for
0, 1, 2, 4, 6 and 24 hours at room temperature. After each
incubation time point the samples were placed in a 0.1 mm quartz
cuvette and, after extensive purging with nitrogen, scanned in the
200 to 260 nm region (scan speed was 20 nm/min). Averages of
five scans were baseline-subtracted (25 mM phosphate with 0.01–
0.02% DMSO, or 25 mM phosphate with 10–20 mM of SLF in
DMSO).
EPR spectroscopy
EPR measurements were carried out in a JEOL TE-100 X-
band spectrometer fitted with a loop-gap resonator as described
previously [23] (JEOL USA, Peabody, MA). SLF (10 mM) was
added to the spin-labeled AbO (40 mM) at a final concentration of
32 mM for 0 and 2 hours prior to EPR measurements.
Appropriate vehicle controls were used for all samples. Approx-
Figure 12. Cultured neuronal cells treated with SLF HO-4160 decrease production of hydrogen peroxide. MC65 cells were cultured in
the presence (TC+) or absence (TC2) of tetracycline, a transgene suppressor of the APP fragment C99. In the absence of tetracycline, cells express the
C99 fragment which is then further cleaved to form Ab. Treatment with either the HO-4160 compound (+4160, 0.3 mM) or the antioxidant vitamin E
(+Vit E, 100 mM) reduces the extracellular accumulation of hydrogen peroxide in cells expressing APP-C99. Error bars represent the SEM for N= 3.
*p,0.05 TC2 compared to both + Vit E and +4160.
doi:10.1371/journal.pone.0035443.g012
Figure 13. Model of action of SLFs on AbO assemblies. The
illustration highlights the bifunctional properties of the SLF, including
its ability to block the formation of nm particles and disrupt small
oligomers, as well as its antioxidant activity. The ability of SLF to disrupt
fibrils or more mature fibrillar oligomers [32] is undetermined.
doi:10.1371/journal.pone.0035443.g013
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imately 5 ml of the protein, at a final concentration of 32 mM was
loaded into a sealed quartz capillary tube. The spectra were
obtained by averaging two 2-minute scans with a sweep width of
100 G at a microwave power of 4 mW and modulation amplitude
optimized to the natural line width of the attached spin probe. All
the spectra were recorded at room temperature.
Antioxidant activity
Measurement of superoxide and hydroxyl free radicals by
EPR. The free radical scavenging activity of SLF compounds
was determined by measuring the adduct levels accumulated by
the spin trap BMPO. Briefly, a mixture of horseradish peroxidase
(100 ng) and 0.03% hydrogen peroxide in PBS pH 7.4 was used to
generate superoxide radicals. Hydroxyl radicals were generated by
mixing ferrous ammonium sulfonate (0.1 mM) and hydrogen
peroxidase (0.1 mM) in PBS. All EPR measurements were
performed in PBS buffer pH 7.4 which contained BMPO
(1 mM) in the presence or absence of SLFs at varied
concentrations. The superoxide and hydroxyl radicals were
measured as BMPO-OOH and BMPO-OH adducts, respectively.
Scavenging of peroxyl and hydroxyl radicals measured by
fluorescence. Fluorescence detection was determined using the
Radical Absorbance Capacity Assay (Cell Biolabs, Inc., San
Diego, CA) according to the manufacturer’s instructions. Briefly,
the indicator is oxidized by ROS species resulting in a loss of
fluorescence. Thus ROS scavenging activity is determined by the
intensity of fluorescence following addition of the hydroxyl or
peroxyl challenge.
Measurement of cellular hydrogen peroxide
levels. MC65 cells were plated onto 12-well plates at 26105
cells per well in Opti-MEM with and without tetracycline (1 mg/
ml). Compounds, such as HO-4160 (0.3 mM) or a-Tocopherol
(referred to as vitamin E, 100 mM, Sigma, St. Louis, MO) were
added to the cultures immediately after plating. Culture medium
was collected after a 24-hour incubation at 37uC. Hydrogen
peroxide in the conditioned medium was analyzed by the Amplex
Red Hydrogen Peroxide/Peroxidase Assay kit following the
instructions of the manufacturer (Invitrogen, Grand Island, NY).
Supporting Information
Figure S1 Structures of SLF compounds [15] evaluated in
Table 1.
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